Literature DB >> 7558128

Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.

J Y Lin1, R Seguin, K Keller, K Chadee.   

Abstract

Nitric oxide (NO) produced by activated macrophages is the major cytotoxic molecule for in vitro cytotoxicity against Entamoeba histolytica trophozoites. Transforming growth factor-beta 1 (TGF-beta 1) is a potent negative regulator of several macrophage functions, including NO production. In this study, we investigated the effect of TGF-beta 1 on macrophage nitric oxide synthase (mac-NOS) mRNA expression and NO production for macrophage cytotoxicity against E. histolytica trophozoites. TGF-beta 1 by itself was incapable of inducing mouse bone marrow-derived macrophage (BMM) amoebicidal activity and NO production (as measured by nitrite). In contrast, TGF-beta 1 pretreatment (4 hr) primed BMM for an enhanced amoebicidal activity of 15% and 23% in response to (interferon-gamma) IFN-gamma+tumour necrosis factor-alpha (TNF-alpha) or IFN-gamma+lipopolysaccharide LPS, concomitant with increased NO production of 85% and 27%, respectively. TGF-beta 1 pretreatment increased NO production in response to IFN-gamma+TNF-alpha/LPS stimulation in a time- and dose-dependent manner. By Northern blot analysis, the increased NO production of TGF-beta 1-pretreated BMM was preceded by markedly enhanced expression of mac-NOS mRNA. The priming effect of TGF-beta 1 on NO production was critically dependent on both a TNF-alpha (> or = 100 U) and a LPS (> or = 100 ng) triggering dose in the presence of IFN-gamma. TGF-beta 1 pretreatment enhanced TNF-alpha mRNA expression, but had no effect on TNF-alpha production in culture supernatants after 4 hr of stimulation with IFN-gamma+TNF-alpha/LPS; however, at a later time-point (16-48 hr), even though the levels of TNF-alpha mRNA expression were unaffected, TNF-alpha production was reduced. These data demonstrate that TGF-beta 1 priming for increased mac-NOS mRNA expression for NO-dependent cytotoxicity against E. histolytica in response to IFN-gamma+TNF-alpha/LPS stimulation may be involved in the modulation of a TNF-alpha triggering signal by TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558128      PMCID: PMC1383913     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma.

Authors:  A Ding; C F Nathan; J Graycar; R Derynck; D J Stuehr; S Srimal
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

2.  Deactivation of macrophages by transforming growth factor-beta.

Authors:  S Tsunawaki; M Sporn; A Ding; C Nathan
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

3.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

Authors:  M Brockhaus; H J Schoenfeld; E J Schlaeger; W Hunziker; W Lesslauer; H Loetscher
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta.

Authors:  G R Welch; H L Wong; S M Wahl
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

5.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).

Authors:  H P Hohmann; R Remy; M Brockhaus; A P van Loon
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

6.  Modulation of cytokine production by transforming growth factor-beta.

Authors:  D Chantry; M Turner; E Abney; M Feldmann
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

7.  Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

Authors:  B J Nelson; P Ralph; S J Green; C A Nacy
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

8.  The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro.

Authors:  T Gatanaga; C D Hwang; M Gatanaga; F Cappuccini; R S Yamamoto; G A Granger
Journal:  Cell Immunol       Date:  1991-11       Impact factor: 4.868

9.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

10.  Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).

Authors:  J S Silva; D R Twardzik; S G Reed
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  3 in total

1.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

2.  DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice.

Authors:  Ibrahim A Hassan; Shuai Wang; LiXin Xu; RuoFeng Yan; XiaoKai Song; Xiangrui Li
Journal:  Parasit Vectors       Date:  2014-09-08       Impact factor: 3.876

Review 3.  A review of the proposed role of neutrophils in rodent amebic liver abscess models.

Authors:  Rafael Campos-Rodríguez; Manuel Gutiérrez-Meza; Rosa Adriana Jarillo-Luna; María Elisa Drago-Serrano; Edgar Abarca-Rojano; Javier Ventura-Juárez; Luz María Cárdenas-Jaramillo; Judith Pacheco-Yepez
Journal:  Parasite       Date:  2016-02-15       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.